Scoopfeeds — Intelligent news, curated.
Campbell's Earnings Beat; Eli Lilly Obesity Drug Results | Stock Movers
business

Campbell's Earnings Beat; Eli Lilly Obesity Drug Results | Stock Movers

Bloomberg Markets · Jun 8, 2026, 3:09 PM · Also reported by 1 other source

On this episode of Stock Movers with Alexis Christoforous: - Shares of The Campbell's Company (CPB) edged higher ahead of the US market open after the canned soup maker reported adjusted earnings per share for the third quarter that beat the average analyst estimate. - Eli Lilly (LLY) shares gained in the early session following obesity drug presentations at the American Diabetes Association conference. Citi analysts say their conviction on Lilly is firmly intact, given the company’s incretin portfolio is “not built around singular blockbusters.” - Shares of Marvell Technology (MRVL) and Flex (FLEX) are rising in premarket trading as the companies are set to replace Pool Corp. and Campbell’s in S&P 500 before the market open on June 22, S&P Dow Jones Indices says in emailed statement. (Source: Bloomberg)

Article preview — originally published by Bloomberg Markets. Full story at the source.
Read full story on Bloomberg Markets → More top stories

Also covered by

Aggregated and edited by the Scoop newsroom. We surface news from Bloomberg Markets alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop